retatrutide fda approval status october 2025 Phase 3 results for have been released, and the data are generating a lot of discussion in obesity medicine. TRIUMPH-1 enrolled 2,339 adults with obesity or overweight and followed participants for October 27, 2025: U.K. regulators

A clear relationship between the severity and incidence of lesions and the amount of T-2 toxin was also demonstrated by Chi et al

This nourishes and rejuvenates the skin by promoting the production of collagen and elastin

While weight loss itself lowers blood pressure, GLP-1 medications reduce blood pressure through direct vascular and metabolic pathways

Better barrier function also supports everyday comfort because healthy skin resists irritation, minor nicks, and dryness more effectively

Extreme/rapid weight loss may result in nutritional deficiencies that lead to hair loss, anemia, weak bones or increased risk of infection